Moreover, in the bone of CKD patients, 1,25(OH)2D has a negligible effect on the expression of the early osteoblast marker, Runt-related transcription factor 2 (RUNX2), and alkaline phosphatase. This evidence concerns the gene RUNX2 and chronic kidney disease.